Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALDX

Aldeyra Therapeutics Inc

May 29 • 04:00PM ET

1.75

0.00 0.00 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AARD AGEN CNTB GALT IMUX KZIA NTHI SPRO VANI VRCA

| Held by: VTI IWM VXF IWO VTWO IWC DFMC VHT PRFZ ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.46	Insider Own	3.18%	Shs Outstand	60.32M	Perf Week	10.06%
Market Cap	105.56M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	4.07%	Shs Float	58.40M	Perf Month	16.67%
Enterprise Value	56.07M	PEG	-	EPS next Q	-0.10	Inst Own	62.24%	Short Float	12.98%	Perf Quarter	-67.95%
Income	-27.37M	P/S	-	EPS this Y	27.68%	Inst Trans	-7.47%	Short Ratio	2.43	Perf Half Y	-66.73%
Sales	0.00M	P/B	2.50	EPS next Y	48.97%	ROA	-34.28%	Short Interest	7.58M	Perf YTD	-66.22%
Book/sh	0.70	P/C	1.62	EPS next 5Y	-	ROE	-51.76%	52W High	6.18 -71.66%	Perf Year	-23.25%
Cash/sh	1.08	P/FCF	-	EPS past 3/5Y	19.04% 12.61%	ROIC	-64.92%	52W Low	1.07 63.55%	Perf 3Y	-81.32%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.71% 6.25%	Perf 5Y	-86.02%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	53.00%	Oper. Margin	-	ATR (14)	0.12	Perf 10Y	-70.98%
Dividend Ex-Date	-	Quick Ratio	2.69	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.59	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.69	EPS Q/Q	65.50%	SMA20	4.60%	Beta	1.18	Target Price	7.00
Payout	-	Debt/Eq	0.37	Sales Q/Q	-	SMA50	3.10%	Rel Volume	0.18	Prev Close	1.75
Employees	8	LT Debt/Eq	0.00	Earnings	Apr 30	SMA200	-58.77%	Avg Volume	3.12M	Price	1.75
IPO	May 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	46.15% -	Trades		Volume	575,690	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)